In April 2011, Boston Biochem Inc was acquired by Techne Corporation. Boston Biochem, Inc. is a producer of Ubiquitin Proteasome Pathway products. Boston Biochem provides customers with reagents for their research needs. All of the firm's specialized reagents are developed, produced and characterized in-house with a commitment to quality and affordability. Boston Biochem provides personalized and knowledgeable customer service and technical services to support product line